Yeongjun James Park1,2,3,4,5,6,7,8, Chia-Hung Yo2, Wan-Ting Hsu3, Eric Po-Yang Tsou4,5, Yu-Chiang Wang6, Dean-An Ling7, An-Fu Lee7, Michael A Liu8, Chien-Chang Lee7. 1. Harvard TH Chan School of Public Health Department of Biostatistics Boston, MA USA. 2. Far Eastern Memorial Hospital Department of Emergency Medicine New Taipei City Taiwan. 3. Harvard TH Chan School of Public Health Department of Epidemiology Boston, MA USA. 4. Johns Hopkins Bloomberg School of Public Health Department of Epidemiology Baltimore USA. 5. Driscoll Children's Hospital Department of Pediatrics Corpus Christi, TX USA. 6. Albert Einstein College of Medicine/Jacobi Medical Center Department of Medicine NY USA. 7. National Taiwan University Hospital Department of Emergency Medicine Taipei Taiwan. 8. Warren Alpert Medical School of Brown University Department of Medicine Providence, RI USA.
Abstract
BACKGROUND: Opioids have been shown to increase risk of pneumonia among susceptible population. However, the effect of opioid abuse on the outcome of pneumonia has not been evaluated at the population level. We aimed to compare the outcomes of pneumonia among patients with opioid use disorder and patients without substance use disorder using a large population database. METHODS: We assembled a pneumonia cohort composed of 11,186,564 adult patients from the National Inpatient Sample (NIS; 2005-2014). Patients with opioid disorder were identified using the International Classification of Diseases, 9th Revision, Clinical Modification codes. We compared health-related and economic outcomes between patients with and without opioid disorders using propensity score matching (PSM) analysis to balance baseline differences. The survival differences between two groups of patients were assessed using a Cox proportional hazard model. We further explored the possibility of effect modification by interaction analyses in different populations. RESULTS: After PSM, patients with opioid use disorder were at increased risk of ventilator use (odds ratio [OR]: 1.22, 95% confidence interval [CI]: 1.08 to 1.38, p = 0.0014) and associated with increased length of hospital stay by 0.59 days (95% CI: 0.35 to 0.83, p < 0.001), compared with those without substance use disorder. Patients with opioid use also had higher daily (228.00 USD, 95% CI: 180.51 to 275.49, p < 0.001) and total (1,875.72 USD, 95% CI: 1,259.63 to 2,491.80, p < 0.001) medical costs. Subgroup analyses showed similar results. CONCLUSIONS: Compared with patients without any drug dependence, patients with opioid use disorders had increased risk of complications and resource utilization. This study adds evidence for increased risk for pneumonia complications in the growing patients with opioid use disorders.
BACKGROUND: Opioids have been shown to increase risk of pneumonia among susceptible population. However, the effect of opioid abuse on the outcome of pneumonia has not been evaluated at the population level. We aimed to compare the outcomes of pneumonia among patients with opioid use disorder and patients without substance use disorder using a large population database. METHODS: We assembled a pneumonia cohort composed of 11,186,564 adult patients from the National Inpatient Sample (NIS; 2005-2014). Patients with opioid disorder were identified using the International Classification of Diseases, 9th Revision, Clinical Modification codes. We compared health-related and economic outcomes between patients with and without opioid disorders using propensity score matching (PSM) analysis to balance baseline differences. The survival differences between two groups of patients were assessed using a Cox proportional hazard model. We further explored the possibility of effect modification by interaction analyses in different populations. RESULTS: After PSM, patients with opioid use disorder were at increased risk of ventilator use (odds ratio [OR]: 1.22, 95% confidence interval [CI]: 1.08 to 1.38, p = 0.0014) and associated with increased length of hospital stay by 0.59 days (95% CI: 0.35 to 0.83, p < 0.001), compared with those without substance use disorder. Patients with opioid use also had higher daily (228.00 USD, 95% CI: 180.51 to 275.49, p < 0.001) and total (1,875.72 USD, 95% CI: 1,259.63 to 2,491.80, p < 0.001) medical costs. Subgroup analyses showed similar results. CONCLUSIONS: Compared with patients without any drug dependence, patients with opioid use disorders had increased risk of complications and resource utilization. This study adds evidence for increased risk for pneumonia complications in the growing patients with opioid use disorders.
Authors: Andrew D Wiese; Marie R Griffin; C Michael Stein; Edward F Mitchel; Carlos G Grijalva Journal: Arthritis Rheumatol Date: 2016-02 Impact factor: 10.995
Authors: Nicholas T Vozoris; Xuesong Wang; Hadas D Fischer; Chaim M Bell; Denis E O'Donnell; Peter C Austin; Anne L Stephenson; Sudeep S Gill; Paula A Rochon Journal: Eur Respir J Date: 2016-07-13 Impact factor: 16.671
Authors: Andrew D Wiese; Marie R Griffin; William Schaffner; C Michael Stein; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva Journal: Ann Intern Med Date: 2018-02-13 Impact factor: 25.391
Authors: Des Breen; Alexander Wilmer; Andrew Bodenham; Vagn Bach; Jan Bonde; Paul Kessler; Sven Albrecht; Soraya Shaikh Journal: Crit Care Date: 2003-11-21 Impact factor: 9.097